BPC-157

Four things to know · April 15, 2026

BPC-157 overview

BPC-157 · Injection

Body Protection Compound-157

Direct tissue targeting for tendon, ligament, and muscle healing.

5 studies cited

Noticed in days · Full benefit in weeks

Days 1-3

Pain relief typically begins as inflammation decreases at the injection site.

Week 1-2

Significant pain reduction and improved mobility are commonly reported.

Week 2-4

Tissue repair typically accelerates with visible improvement in function.

Week 4-8

Most injuries are typically substantially improved with continued healing.

Direct tissue targeting for tendon, ligament, and muscle healing. The injection form delivers BPC-157 locally near the injury site for maximum repair effect. Half-life of 4 hours provides sustained local concentrations. This is the most studied route.

DOSING

Injection protocols

ProtocolDoseFrequency
Tendon/joint healing250-500mcg1-2x daily
Serious injury500-1000mcg2x daily
General healing250-500mcg1-2x daily
Maintenance250mcg1x daily

Protocols are from published research literature. This is not medical advice. Dosing should be determined by a licensed clinician.

What people report

Days 1-3

Pain relief typically begins as inflammation decreases at the injection site.

Week 1-2

Significant pain reduction and improved mobility are commonly reported.

Week 2-4

Tissue repair typically accelerates with visible improvement in function.

Week 4-8

Most injuries are typically substantially improved with continued healing.

What to know

  • Inject near the injury site on an empty stomach for the strongest local effect
  • Mild redness or swelling at the injection site is common and temporary
  • Use caution if you take blood thinners, as BPC-157 promotes blood vessel growth
  • Avoid during pregnancy or breastfeeding
  • Prohibited by WADA (World Anti-Doping Agency). Not cleared for competitive sports, and no medical exemption is available
  • Talk to a healthcare provider before starting, especially if you have existing conditions
HOW IT WORKS

How BPC-157 works

When injected near an injury, BPC-157 concentrates locally rather than dispersing through the body. It works by triggering the growth of new blood vessels around damaged tissue, ramping up collagen production, and activating growth factors that accelerate the repair process. The reported effect is typically faster healing with improved tissue quality at the site.

BEST FOR

Key benefits

  • Supports gastrointestinal repair and gut lining protection
  • Promotes new blood vessel growth around injured tissue
  • Accelerates healing across tendons, ligaments, muscles, and bones
  • Strengthens connective tissue through increased collagen production
  • Reduces local inflammation at the injury site
REGULATORY STATUS

Regulatory status

Category 2. The FDA's pharmacy compounding advisory committee is scheduled to review BPC-157 on July 23, 2026, for potential addition to the 503A bulks list. The use under review: gut inflammation and inflammatory bowel conditions (ulcerative colitis). No formal rule change yet. Not FDA approved. Prohibited by WADA (added 2022) under S0, with no medical exemption available for athletes.

KEY RESEARCH · 5 PAPERS CITED

Lee E et al.

Alternative Therapies in Health and Medicine

2025

Read paper →

Xu C et al.

Regulatory Toxicology and Pharmacology

2020

Read paper →

Perovic D et al.

Journal of Orthopaedic Surgery and Research

2019

Read paper →

Park JM et al.

Gut and Liver

2019

Read paper →

Chang CH et al.

Journal of Orthopaedic Surgery and Research

2019

Read paper →

The Pep Dispatch

Follow the evidence on BPC-157 as it evolves.

Subscribe to find out what.

Next dispatch · May 2026 · Honest frequency: a few times a month

For the people who want to feel better — not just look up symptoms.